Citation of paper, Merck's perspective on the implementation of dried blood spot technology in clinical drug development - why, when and how

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
Kevin P Bateman6782,9923.9
Neil Spooner4602,6944.5
Christophe P Stove41974,4594.5
Jörg Huwyler22389,3704.9
Urs Duthaler2548383.4
Regina V Oliveira2491,0551.9
Isabel Meister2173556
Giuseppe Paglia1652,8216.3
Sung-Chun Tang11985,2803.2
Denni Joko Purwanto110622.5
Chiara Volani1112184.2
Xinliu Gao14263.8
Christoph Borchers132316,5475.4
Hsi-Chun Chao1141182.4
Hsiao-Wei Liao1303982.6
Ramesh Mullangi11055981.1
Peter P Pramstaller120231,70517.8
Chi-Chung Li1259015.1
Brad Roadcap1173.5
Johannes Rainer1451,5355.9
Lori Rosman, Mls1182434.4
Marissa F Dockendorf1154135.7
Nuggehally R Srinivas12462,8881.1
Trine Grønhaug Halvorsen1611,4912.6
Douglas F Stickle1606830.8
Jiann-Shing Jeng12325,0433
Anne B Chang151313,3612.8
Teng Liu161214.5
Lisa Delahaye1121374.9
Anna Neodo19812.7
Somphou Sayasone1791,5713.2
Aurelien Thomas11013,0904.4
Jeremy D Ratcliff11996432.4
Andrew A Hicks118233,99121.6
Ching-Hua Kuo11211,7172.8
Michael J Binks19941.8